Please use this identifier to cite or link to this item:
|Title:||Enhanced solid-state stability of amorphous ibrutinib formulations prepared by hot-melt extrusion||Authors:||Simões, Marta F.
Nogueira, Bernardo A.
Tabanez, Andreia M.
Pinto, Rui M. A.
|Keywords:||Amorphous solid dispersions; Hot-melt extrusion; Ibrutinib; Multivariate statistics; Polymers; Principal components analysis||Issue Date:||16-Feb-2020||Publisher:||Elsevier||Project:||info:eu-repo/grantAgreement/FCT/PD/BDE/135149/2017/PT
|Serial title, monograph or event:||International Journal of Pharmaceutics||Volume:||579||Abstract:||One of the applications of Hot-Melt Extrusion (HME) is the stabilization of amorphous drugs through its incorporation into polymeric blends in the form of Amorphous Solid Dispersions (ASDs). In this study, HME was applied to solve a real problem in the development of an ibrutinib product, stabilizing the amorphous form. A systematic approach was followed by combining theoretical calculations, high-throughput screening (HTS) focused on physical stability and Principal Components Analysis (PCA). The HTS enabled the evaluation of 33 formulations for physical stability and the PCA was key to select four promising systems. The low relevance of drug loading on the drug crystallization supported the HME tests with a very high drug load of 50%. Milled extrudates were characterized and demonstrated to be fully amorphous. The thermal analysis detected a glass transition temperature much higher than the predicted values. Along with several weak intermolecular interactions detected in Raman spectroscopy, a dipolar interaction involving the α, β unsaturated ketone function of ibrutinib was also noticed. The additive effect of these intermolecular interactions changed markedly the performance of the ASDs. The physical strength of the prepared systems was corroborated by stability studies until 6 months at long-term and accelerated conditions.||URI:||http://hdl.handle.net/10316/91157||ISSN:||03785173||DOI:||10.1016/j.ijpharm.2020.119156||Rights:||embargoedAccess|
|Appears in Collections:||I&D CQC - Artigos em Revistas Internacionais|
Show full item record
Files in This Item:
|Intl_J_Pharmaceut_579_2020_119156.pdf||1.88 MB||Adobe PDF||View/Open|
WEB OF SCIENCETM
checked on Oct 2, 2021
checked on Oct 8, 2021
checked on Oct 8, 2021
This item is licensed under a Creative Commons License